Higher whole blood expression of FAM53A and PPP1R2 was associated with higher odds of bladder cancer, while higher expression of SLC39A3 and ZNF737 was associated with lower odds of bladder cancer. This evidence concerns the gene SLC39A3 and urinary bladder cancer.